title: Breast tomosynthesis. 3-D mammography reaches the U.S. market.
abstract: After many years of anticipation, FDA has approved a device for breast tomosynthesis applications: The Hologic Selenia Dimensions 3-D. But despite the advantages of the technology, certain issues--such as increased radiation dose, higher costs, and lack of insurance reimbursement--may impede widespread clinical adoption. We take a look at breast tomosynthesis and give our view on its clinical outlook.
mesh_terms: D001943:Breast Neoplasms / Q000000981:diagnostic imaging*; D005260:Female; D006801:Humans; D007349:Insurance, Health, Reimbursement; D008327:Mammography / Q000295:instrumentation*; D011829:Radiation Dosage; D011856:Radiographic Image Enhancement / Q000295:instrumentation*; D014481:United States